Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on July 31, 2025
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
GlobeNewswire
·
July 31, 2025
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 NOVATO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical …
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
GlobeNewswire
·
July 31, 2025
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on …
Orchestra BioMed Announces Proposed Public Offering
GlobeNewswire
·
July 31, 2025
NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
GlobeNewswire
·
July 31, 2025
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an …
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
GlobeNewswire
·
July 31, 2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, after the close of the U.S. financial …
Asure Announces Second Quarter 2025 Results
GlobeNewswire
·
July 31, 2025
Second Quarter 2025 Total Revenues Increased 7% to $30.1 million Recurring Revenues Grew 6% from Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading …
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
GlobeNewswire
·
July 31, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET …
Ruanyun Edai Technology Announces Financial Results for Fiscal Year 2025
GlobeNewswire
·
July 31, 2025
NANCHANG, China, July 31, 2025 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (NASDAQ: RYET), a leading AI-powered education technology company in China, today announced its financial results for the fiscal year ended March …
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
GlobeNewswire
·
July 31, 2025
Daix (France), New York (New York, Etats-Unis), le 31 juillet 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le …
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
GlobeNewswire
·
July 31, 2025
Daix (France), New York (New York, United States), July 31, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the …
Nephros Schedules Second Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
July 31, 2025
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial …
ZenaDrone de ZenaTech inicia la actualización de su membresía en AUVSI, lo que permite el liderazgo en la política de drones y fortalece la colaboración con el sector de defensa y el gobierno de EE.UU.
GlobeNewswire
·
July 31, 2025
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones de tecnología empresarial especializado en drones con IA (Inteligencia Artificial), Dron como un …
SONY Joins the AR Alliance to Advance the Future of Augmented Reality Wearable Devices
GlobeNewswire
·
July 31, 2025
PISCATAWAY, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- The AR Alliance announces that SONY has joined the alliance as an associate member. The AR Alliance provides a supportive and neutral environment for organizations of all sizes to take an active role in …
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
GlobeNewswire
·
July 31, 2025
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3 Type 1 Diabetes (T1D) appears sufficient to support the Prospect …
Telnyx Supercharges European Voice AI with Paris GPU Edge, Breaking 200ms Latency Barrier
GlobeNewswire
·
July 31, 2025
AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Telnyx, the vertically integrated operator powering low-latency voice AI agents, today lit up a new GPU-accelerated Voice-AI Point-of-Presence (PoP) in Paris, France. By embedding its inference stack …
The AR Alliance Welcomes Magic Leap, Tekscend Photomask, and UC San Diego as New Members
GlobeNewswire
·
July 31, 2025
PISCATAWAY, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- The AR Alliance a program of the ISTO federation that is dedicated to advancing open and interoperable augmented reality (AR) ecosystem standards, proudly announces the addition of four influential …
BioPREVAIL Launches Call for Proposals in World Design Challenge for Sustainable Diagnostic Containment Laboratories
EIN Presswire
·
July 31, 2025
Global Affair's Canada, World Organisation for Animal Health, and Global Health Security Fund Unite to Foster Innovation for One Health Security Initiative GENEVA, SWITZERLAND, July 31, 2025 /EINPresswire.com/ -- BioPREVAIL, a One Health Security …
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment
GlobeNewswire
·
July 31, 2025
Access the “What This Means” segment here LA JOLLA, CA, July 31, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the …
The Pink Salt Trick Recipe for Fast Weight Loss Trend in 2025: Why Trimology Is the Science-Backed Alternative
GlobeNewswire
·
July 31, 2025
New York City, NY, July 31, 2025 (GLOBE NEWSWIRE) -- Pink Salt Trick Recipe Explained: Why It’s Trending for Weight Loss A viral wellness trend called the “Pink Salt Trick” has swept social media—particularly TikTok, Instagram, and wellness blogs. The hype …